Insider Activity: Warning Aceto Corporation (NASDAQ:ACET) optimists! Satish Srinivasan just Unloaded 12,917 shares.

November 30, 2016 - By Winifred Garcia

Insider Activity: Warning Aceto Corporation (NASDAQ:ACET) optimists! Satish Srinivasan just Unloaded 12,917 shares.

Satish Srinivasan Insider Sell

In a legal form that’s submitted to the Security Exchange Commission, it was stated that the President & COO – Rising Pharm of Aceto Corp Satish Srinivasan, an insider in focus, made sale through a broker for 12,917 shares of the public firm, having a market value of $258,534 US Dollars using the average stock value of $20.0 US Dollars. Mr. Satish today holds 20,434 shares, accounting for 0.07% of the Company’s stock market capitalization.

Insitutional Activity: The institutional sentiment increased to 1.22 in Q2 2016. Its up 0.36, from 0.86 in 2016Q1. The ratio is positive, as 16 funds sold all Aceto Corporation shares owned while 49 reduced positions. 11 funds bought stakes while 45 increased positions. They now own 23.91 million shares or 7.56% less from 25.86 million shares in 2016Q1.

Nomura Holdings has invested 0.01% of its portfolio in Aceto Corporation (NASDAQ:ACET). Lsv Asset Management holds 6,800 shares or 0% of its portfolio. Victory Capital Management Incorporated holds 0% of its portfolio in Aceto Corporation (NASDAQ:ACET) for 2,395 shares. Motley Fool Asset Mngmt Lc has invested 0.98% of its portfolio in Aceto Corporation (NASDAQ:ACET). Pacad Limited has invested 0% of its portfolio in Aceto Corporation (NASDAQ:ACET). Ftb Advsrs reported 121 shares or 0% of all its holdings. The Illinois-based Guggenheim Cap Lc has invested 0% in Aceto Corporation (NASDAQ:ACET). The Florida-based Ladenburg Thalmann has invested 0% in Aceto Corporation (NASDAQ:ACET). Pnc Financial Grp holds 0% or 15,754 shares in its portfolio. Thompson Siegel Walmsley Ltd Liability holds 64 shares or 0% of its portfolio. Sunbelt Securities accumulated 7,000 shares or 0% of the stock. Thomson Horstmann Bryant last reported 200,466 shares in the company. Blackrock Advsr Limited holds 0% or 14,042 shares in its portfolio. Teachers Advisors accumulated 47,406 shares or 0% of the stock. Blackrock Investment Management Limited Co last reported 0% of its portfolio in the stock.

Insider Transactions: Since May 31, 2016, the stock had 0 buys, and 32 selling transactions for $3.34 million net activity. $15,161 worth of shares were sold by Srinivasan Satish on Tuesday, July 19. Bartone Raymond also sold $53,605 worth of Aceto Corporation (NASDAQ:ACET) shares. ROTH DOUGLAS A sold $205,520 worth of stock. Another trade for 2,167 shares valued at $43,418 was sold by Rogers Steven. 2,567 Aceto Corporation (NASDAQ:ACET) shares with value of $50,955 were sold by Alaimo Charles John. Kippley Terry sold 2,000 shares worth $45,000. Shares for $90,926 were sold by DEBENEDITTIS FRANK.

About 198,459 shares traded hands. Aceto Corporation (NASDAQ:ACET) has declined 13.99% since April 27, 2016 and is downtrending. It has underperformed by 19.21% the S&P500.

Aceto Corporation is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The company has a market cap of $622.30 million. The Company’s business is organized along product lines into three divisions: Human Health, Pharmaceutical Ingredients and Performance Chemicals. It has a 20.3 P/E ratio. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries.

According to Zacks Investment Research, “Aceto Corporation markets, sells and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products and specialty chemicals. The company’s operating segment consists of Human Health, Pharmaceutical Ingredients and Performance Chemicals. Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements. It markets and distributes its generic prescription and over the counter pharmaceutical products. Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates. Performance Chemicals segment provides specialty chemicals. It serves chemical, agricultural, human health and pharmaceutical industries. The company operates primarily in United States, Europe, and Asia. Aceto Corporation and is headquartered in Port Washington, New York.”

Analysts await Aceto Corporation (NASDAQ:ACET) to report earnings on February, 2. They expect $0.35 EPS, down 2.78% or $0.01 from last year’s $0.36 per share. ACET’s profit will be $10.65 million for 14.61 P/E if the $0.35 EPS becomes a reality. After $0.28 actual EPS reported by Aceto Corporation for the previous quarter, Wall Street now forecasts 25.00% EPS growth.

More notable recent Aceto Corporation (NASDAQ:ACET) news were published by: Fool.com which released: “Why Shares of Aceto Corporation Plunged 23% Today” on August 26, 2016, also Streetinsider.com with their article: “ACETO Corp (ACET) Announces $412M Acquisition of Certain Assets from Citron ..” published on November 03, 2016, Globenewswire.com published: “ACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results ..” on August 12, 2016. More interesting news about Aceto Corporation (NASDAQ:ACET) were released by: Globenewswire.com and their article: “ACETO Corporation Announces $125 Million Convertible Notes Offering” published on November 09, 2015 as well as Quotes.Wsj.com‘s news article titled: “News Aceto Corp.ACET” with publication date: February 13, 2011.

ACET Company Profile

Aceto Corporation (Aceto), incorporated on June 13, 1947, is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company’s business is organized along product lines into three divisions: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, the Company distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. The Firm has presence in China, Germany, France, The Netherlands, Singapore, India, Hong Kong, Philippines, the United Kingdom and the United States.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>